NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus

European Journal of Pharmacology

Volumn 380, Issue 2-3, 1999, Pages 91-99

  Bond, Ann ^a   Lodge, David ^a   Hicks, Caroline A ^a   Ward, Mark A ^a   O'Neill, Michael J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

AMPA receptor; Hippocampus gerbil; Ischaemic tolerance; LY293558; MK 801; Neuroprotection; NMDA receptor

Indexed keywords

AMPA RECEPTOR ANTAGONIST; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN ISCHEMIA; CELL COUNT; CELL SURVIVAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; ISOQUINOLINES; MALE; NEURONS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; TETRAZOLES;

EID: 0032836405     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00523-3     Document Type: Article

References (62)

1. Barone F.C., Feuerstein G.Z., White R.F. Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci. Biobehav. Rev. 21:1997;31-44.
2. Boxer P.A., Bigge C.F. Mechanisms of neuronal cell injury/death and targets for drug intervention. Drug Discovery Today. 2:1997;219-228.
3. Brierley, J.B., Graham, D.I., 1984. Hypoxia and vascular disorders of the central nervous system. In: Adams, J.H., Corselis, J.A.N., Duchen, L.W. (Eds.), Greenfield's Neuropathology, 4th edn. Edward Arnold, London, pp. 125-207.
4. Buchan A.M., Pulsinelli W.A. Hypothermia, but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10:1990;311-316.
5. Bullock R., Graham D.I., Chen M.-H., Lowe D., McCulloch J. Focal cerebral ischemia in the cat: pre-treatment with a competitive NMDA receptor antagonist, D-CPP-ene. J. Cereb. Blood Flow Metab. 10:1990;668-674.
6. Bullock R., Graham D.I., Swanson S., McCulloch J. Neuroprotective effect of the AMPA receptor antagonist LY293558 in focal ischemia in the cat. J. Cereb. Blood Flow Metab. 14:1994;466-471.
7. Busto R., Dietrich W.D., Globus M.Y.-T., Valdes I., Scheinberg P., Ginsberg M.D. Small differences in intra-ischemic brain temperature critically determine the extent of ischaemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
8. Busto R., Dietrich W.D., Globus M.Y.-T., Ginsberg M.D. Post-ischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci. Lett. 101:1989;299-304.
9. Butcher S.P., Bullock R., Graham D.I., McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21:1990;1727-1733.
10. Chen T., Kato H., Xiao-Hong L., Araki T., Itoyama Y., Kogure K. Ischemic tolerance can be induced repeatedly in the gerbil hippocampal neurons. Neurosci. Lett. 177:1994;159-161.
11. Chen J., Zhu R.L., Nakayama M., Kawaguchi K., Jin K., Stetler R.A., Simon R.P., Graham S.H. Expression of the apoptosis-effector gene, bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J. Neurochem. 67:1996;64-71.
12. Colbourne F., Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654:1994;265-272.
13. Corbett D., Evans S., Thomas C., Wang D., Jones R.A. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res. 514:1990;300-304.
14. Crain B.J., Westerkam W.D., Harrisson A.H., Nadler J.V. Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil. Neuroscience. 27:1988;387-402.
15. Del Zoppo G.J., Wagner S., Tagaya M. Trends and future developments in the pharmacological treatment of acute stroke. Drugs. 54:1997;9-38.
16. Dietrich W.D., Busto R., Alonso O., Globus M.Y.-T., Ginsberg M.D. Intra-ischemic but not post-ischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 13:1993;541-549.
17. Gill R. The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 6:1994;225-256.
18. Gill R., Lodge D. The neuroprotective effects of the decahydroisoquinoline, LY215490; a novel AMPA antagonist in focal ischaemia. Neuropharmacology. 33:1995;1529-1536.
19. Gill R., Nordholm L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brain Res. 580:1992;35-43.
20. Grabb M.C., Choi D.W. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 19:1999;1657-1662.
21. Graham S.H., Chen J., Lan J.Q., Simon R.P. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. J. Pharmacol. Exp. Ther. 276:1996;1-4.
22. Green E.J., Pazos A.J., Dietrich W.D., McCabe P.M., Schneiderman N., Lin B., Busto R., Globus M.Y.-T., Ginsberg M.D. Combined post-ischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res. 701:1995;145-152.
23. Hayward N.J., McKnight A.T., Woodruff G.N. Brain temperature and the neuroprotective action of enadoline and dizocilipine in the gerbil model of global-ischemia. Eur. J. Pharmacol. 236:1993;247-253.
24. Hicks C.A., Ward M.A., Ragumoorthy N., Ambler S.J., Dell C.P., Dobson D., O'Neill M.J. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia. Brain Res. 819:1999;65-74.
25. Ikeda J., Nakajima T., Osborne O.C., Mies G., Nowak T.S. Coexpression of c-fos and hsp70 mRNAs in gerbil brain ischemia: induction threshold, distribution and time course evaluated by in situ hybridization. Mol. Brain Res. 26:1994;249-258.
26. Kasischke K., Ludolph A.C., Riepe M.W. NMDA antagonists reverse increased hypoxic tolerance by preceding chemical hypoxia. Neurosci. Lett. 214:1996;175-178.
27. Kato H., Yong L., Tsutomu A., Kogure K. MK-801, but not anisomysin, inhibits the induction of tolerance to ischemia in the gerbil hippocampus. Neurosci. Lett. 139:1992;118-121.
28. Kato H., Araki T., Itoyama Y., Kogure K., Kato K. An immunohistochemical study of heat shock protein-27 in the hippocampus in a gerbil model of cerebral ischemia and ischemic tolerance. Neuroscience. 1:1995;65-71.
29. Kato H., Kogure K., Araki T., Itoyma Y. Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res. 694:1995;85-93.
30. Kato H., Kogure K., Liu X., Araki T., Kato K., Itoyama Y. Immunohistochemical localization of the low molecular weight stress protein HSP-27 following focal cerebral ischemia in the rat. Brain Res. 679:1995;1-7.
31. Kawasaki-Yatsugi S., Yatsugi S., Takahashi M., Toya T., Ichiki C., Shimizu-Sasamata M., Yamaguchi T., Minematsu K. A novel AMPA receptor antagonist, YM872, reduces infarct after middle cerebral artery occlusion in rats. Brain Res. 793:1998;39-46.
32. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1:1982;494-498.
33. Kirino T., Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 62:1984;201-208.
34. Kirino T., Yoshihiko T., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11:1991;299-307.
35. Koek W., Woods J.H., Winger G.D. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:1988;969-974.
36. Lees K.R. Cerestat and other NMDA antagonists in ischemic stroke. Neurology. 49:1997;S66-S69.
37. Levy D.E., Brierley J.B., Plum F. Ischemic brain damage in the gerbil in the absence of "no-reflow" J. Neurol., Neurosurg. Psychiatry. 38:1975;1197-1205.
38. Li H., Buchan A.M. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13:1993;933-939.
39. Li Y., Chopp M., Zhang Z.G., Zhang R.L. Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J. Neurol. Sci. 128:1995;134-142.
40. Lodge D., Bond A., O'Neill M.J., Hicks C.A., Jones M.G. Stereoselective effects of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology. 35:1996;681-1688.
41. Marini A.M., Paul S.M. N-Methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6555-6559.
42. Matsushima K., Hakim A.M. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion. Stroke. 26:1994;1047-1052.
43. McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br. J. Clin. Pharmacol. 34:1992;106-114.
44. Monaghan D.T., Bridges R., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Ann. Rev. Pharmacol. Toxicol. 29:1989;314-320.
45. Morris R.G.M., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-0776.
46. Nakata N., Kato H., Kogure K. Effects of repeated cerebral ischemia on extracellular amino acid concentrations measured with intracerebral microdialysis in the gerbil hippocampus. Stroke. 24:1993;458-463.
47. Nowak T.S. Jr. Synthesis of a stress protein following transient ischemia in the gerbil. J. Neurochem. 45:1985;1635-1641.
48. Nurse S., Corbett D. Neuroprotection after several days of mild, drug-induced hypothermia. J. Cereb. Blood Flow. Metab. 16:1996;474-480.
49. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phenyclidine and related drugs. Science. 244:1990;1360-1362.
50. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
51. O'Neill M.J., Bond A., Ornstein P.L., Hicks C.A., Ward M.A., Hoo K., Bleakman D., Lodge D. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology. 37:1998;1211-1222.
52. Park C.K., Nehls D.G., Graham D.I., Teasdale G.M., McCulloch J. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after the induction of ischaemia. J. Cereb. Blood Flow Metab. 8:1988;757-762.
53. Park C.K., McCulloch J., Kang J.K., Choi C.R. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat. Neurosci. Lett. 147:1992;41-44.
54. Raghupathi R., Welsh F.A., Lowenstein D.H., Gennarelli T.A., McIntosh T.K. Regional induction of c-fos and heat shock protein-72 mRNA following fluid-percussion brain injury in the rat. J. Cereb. Blood Flow Metab. 15:1995;467-473.
55. Sheardown M.J., Nielson E.O., Hansen A.J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia. Science. 247:1990;571-574.
56. Sheardown M.J., Suzdak P.D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia. Eur. J. Pharmacol. 236:1993;347-353.
57. Shimizu-Sasamata M., Kano, Rogowska J., Wolf G.L., Moskowitz M.A. YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rat. Stroke. 29:1998;2141-2148.
58. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
59. Uemura Y., Kowell N.W., Beal M.F. Global ischemia induces NMDA receptor-mediated c-fos expression in neurons resistant to injury in gerbil hippocampus. Brain Res. 542:1991;343-347.
60. Vass K., Welch W.J., Norwak T.S. Localisation of 70-kDa stress protein induction in gerbil brain after ischaemia. Acta Neuropathol. 77:1988;128-135.
61. Xue D., Huang Z.-G., Barnes K., Lesiuk -H.J., Smith K.E., Buchan A.M. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14:1994;251-261.
62. Yatsugi S., Takahashi M., Kawasaki-Yatsugi S., Koshiya K., Sakamoto S., Uematsu D., Shimizu-Sasamata M. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats. J. Cereb. Blood Flow Metab. 16:1996;959-966.